Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population

Phoenix Children's Hospital

Overview

The primary objective of this study is to evaluate the efficacy and safety tamsulosin in reducing stent discomfort in the pediatric population in the peri-operative period. The secondary objective is to compare the efficacy of tamsulosin with that of oxybutynin in reducing stent discomfort.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Conditions

Disorder of Urinary Stent

Interventions

TamsulosinDRUG

OxybutyninDRUG

Eligibility

Sex: ALLMin age: 4 YearsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients aged 4-18 years will be enrolled in this study. We will include all patients who will have a ureteral stent placement after their procedure. Exclusion Criteria: * Patients with developmental delay or unable to verbalize their pain level will be excluded.

Outcomes

Primary Outcomes

Number of doses of pain in medication used

After surgery, each child will be prescribed the standard dosage of oxycodone/acetaminophen based on their weight. We will have the patient's family record the number of doses of narcotics used from post-operative day #1 to post-operative day #5 to assess their pain needs.

Time frame: 5 days post-op

Pain scale based on the faces pain score

We will have the family members record the child's pain score in the morning and evening using the faces pain scale and record the score.

Time frame: 5 days post-op

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.